Overview
- 116 inspections across 114 sites are on record.
- 258 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-07-02.
At a glance
Inspections
116
Sites
114
Observations
258
Career since
Jul 2012
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Serum Institute of India Private Ltd. | 2 Jul 2024 | Biologics | On file |
| Sharp Sterile Manufacturing, LLC | 12 Jun 2024 | Biologics | On file |
| ModernaTX, Inc. | 19 Apr 2024 | Biologics | |
| Novartis Pharmaceutical Manufacturing GmbH | 22 Mar 2024 | Biologics | |
| GlaxoSmithKline Biologicals | 12 Mar 2024 | Biologics | On file |
Sites inspected
Serum Institute of India Private Ltd.Pune, India1 insp.
Sharp Sterile Manufacturing, LLCLee, United States1 insp.
ModernaTX, Inc.Norwood, United States1 insp.
Novartis Pharmaceutical Manufacturing GmbHKundl, Austria1 insp.
GlaxoSmithKline BiologicalsSaint-Amand-Les-Eaux, France1 insp.
Co-investigators
Investigators who share inspections with this person.
Massoud Motamed5 shared
Tara A Gray5 shared
Stephanie D Crockett4 shared
Shelby N Marler4 shared
Susan M Jackson3 shared
Matthew R Maddox3 shared
Casey L Hamblin3 shared
Cathleen A Castellaw3 shared
Rebecca Rodriguez2 shared
Saied A Asbagh2 shared
Full investigator report
Get the verbatim findings behind Latorie S Jones' 258 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site